These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3585592)

  • 21. Plugs for drugs.
    Masson A; Rubin PH
    Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract]   [Full Text] [Related]  

  • 22. International illicit drug traffic: the United States response.
    Williamson RS
    Bull Narc; 1983; 35(4):33-45. PubMed ID: 6563924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Illegal drug trade discovered in Bavaria. How can we protect ourselves from drug falsification?].
    Schweim HG
    MMW Fortschr Med; 2005 Sep; 147(38):11. PubMed ID: 16218221
    [No Abstract]   [Full Text] [Related]  

  • 24. Protecting consumers from counterfeit drugs.
    FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838
    [No Abstract]   [Full Text] [Related]  

  • 25. Have we won the drug war yet?
    Robinson JA
    J Okla State Med Assoc; 2012 Aug; 105(8):310-1. PubMed ID: 23091975
    [No Abstract]   [Full Text] [Related]  

  • 26. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nonmedical use of amphetamines among the college age group: recent research concerning epidemiology and toxicity.
    Nicholi AM
    J Am Coll Health; 1984 Aug; 33(1):39-43. PubMed ID: 6501713
    [No Abstract]   [Full Text] [Related]  

  • 28. Children and drug smuggling.
    Osterhoudt KC
    Arch Pediatr Adolesc Med; 2003 Jul; 157(7):703. PubMed ID: 12860794
    [No Abstract]   [Full Text] [Related]  

  • 29. Judge allows bulk ingredients for compounding: ruling favors pharmacy, but FDA can still distinguish manufacturing, compounding.
    Cima G
    J Am Vet Med Assoc; 2011 Nov; 239(10):1266-68. PubMed ID: 22044321
    [No Abstract]   [Full Text] [Related]  

  • 30. Illicit drug use should not be legalized.
    Rosner F; Wolpaw J; Sechzer PH; Rogatz P; Risemberg HM; Ona FV; Numann PJ; Lowenstein R; Loeb L; Landolt AB
    N Y State J Med; 1992 Feb; 92(2):59-62. PubMed ID: 1565313
    [No Abstract]   [Full Text] [Related]  

  • 31. Has the Food and Drug Administration abused its authority in attempting to regulate veterinary compounding?
    Siegner AW
    J Am Vet Med Assoc; 1994 Jul; 205(2):243-7. PubMed ID: 7928589
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 33. Compounding of drugs in equine practice.
    Lenz TR; Kanara EW; Becht JL
    J Am Vet Med Assoc; 1994 Jul; 205(2):207-9. PubMed ID: 7928577
    [No Abstract]   [Full Text] [Related]  

  • 34. Children and drug law reform.
    Cardoso FH
    Int J Drug Policy; 2012 Jan; 23(1):1-2. PubMed ID: 22071021
    [No Abstract]   [Full Text] [Related]  

  • 35. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
    Reichertz PS
    Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
    [No Abstract]   [Full Text] [Related]  

  • 36. Street drug misrepresentation.
    Falck R; Seal M
    JAMA; 1980 Jul; 244(4):332. PubMed ID: 7392120
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: Those "ingredients most used by doctors".
    Ingelfinger FJ
    N Engl J Med; 1976 Sep; 295(11):616-7. PubMed ID: 986005
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescription for crime.
    Bowman R
    Time; 2005 Mar; 165(13):50-1. PubMed ID: 15806984
    [No Abstract]   [Full Text] [Related]  

  • 39. The changing face of teenage drug abuse--the trend toward prescription drugs.
    Friedman RA
    N Engl J Med; 2006 Apr; 354(14):1448-50. PubMed ID: 16598042
    [No Abstract]   [Full Text] [Related]  

  • 40. The necessity and utility of abuse liability evaluations in human subjects: the FDA perspective.
    Vocci FJ
    NIDA Res Monogr; 1989; 92():7-20. PubMed ID: 2512503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.